# Dynamics of MSI and Genomic Profile of Colorectal Cancer In the Course of Immune Checkpoint Inhibitor Therapy

> **NCT06414304** · — · COMPLETED · sponsor: **OncoAtlas LLC** · enrollment: 30 (actual)

## Conditions studied

- Colorectal Cancer
- Colorectal Cancer Metastatic
- MSI-H Colorectal Cancer
- dMMR Colorectal Cancer
- Cancer
- Colon Adenocarcinoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06414304
- **Lead sponsor:** OncoAtlas LLC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-01
- **Primary completion:** 2024-09-01
- **Final completion:** 2025-03-01
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2025-06-27

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06414304

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06414304, "Dynamics of MSI and Genomic Profile of Colorectal Cancer In the Course of Immune Checkpoint Inhibitor Therapy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06414304. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*